Literature DB >> 31549945

Simple Adnexal Cysts: SRU Consensus Conference Update on Follow-up and Reporting.

Deborah Levine1, Maitray D Patel1, Elizabeth J Suh-Burgmann1, Rochelle F Andreotti1, Beryl R Benacerraf1, Carol B Benson1, Wendy R Brewster1, Beverly G Coleman1, Peter M Doubilet1, Steven R Goldstein1, Ulrike M Hamper1, Jonathan L Hecht1, Mindy M Horrow1, Hye-Chun Hur1, Mary L Marnach1, Ed Pavlik1, Lawrence D Platt1, Elizabeth Puscheck1, Rebecca Smith-Bindman1, Douglas L Brown1.   

Abstract

This multidisciplinary consensus update aligns prior Society of Radiologists in Ultrasound (SRU) guidelines on simple adnexal cysts with recent large studies showing exceptionally low risk of cancer associated with simple adnexal cysts. Most small simple cysts do not require follow-up. For larger simple cysts or less well-characterized cysts, follow-up or second opinion US help to ensure that solid elements are not missed and are also useful for assessing growth of benign tumors. In postmenopausal women, reporting of simple cysts greater than 1 cm should be done to document their presence in the medical record, but such findings are common and follow-up is recommended only for simple cysts greater than 3-5 cm, with the higher 5-cm threshold reserved for simple cysts with excellent imaging characterization and documentation. For simple cysts in premenopausal women, these thresholds are 3 cm for reporting and greater than 5-7 cm for follow-up imaging. If a cyst is at least 10%-15% smaller at any time, then further follow-up is unnecessary. Stable simple cysts at initial follow-up may benefit from a follow-up at 2 years due to measurement variability that could mask growth. Simple cysts that grow are likely cystadenomas. If a previously suspected simple cyst demonstrates papillary projections or solid areas at follow-up, then the cyst should be described by using standardized terminology. These updated SRU consensus recommendations apply to asymptomatic patients and to those whose symptoms are not clearly attributable to the cyst. These recommendations can reassure physicians and patients regarding the benign nature of simple adnexal cysts after a diagnostic-quality US examination that allows for confident diagnosis of a simple cyst. Patients will benefit from less costly follow-up, less anxiety related to these simple cysts, and less surgery for benign lesions. © RSNA, 2019See also the editorial by Grant in this issue.

Entities:  

Mesh:

Year:  2019        PMID: 31549945     DOI: 10.1148/radiol.2019191354

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  5 in total

1.  Decoding incidental ovarian lesions: use of texture analysis and machine learning for characterization and detection of malignancy.

Authors:  Hyesun Park; Lei Qin; Pamela Guerra; Camden P Bay; Atul B Shinagare
Journal:  Abdom Radiol (NY)       Date:  2020-07-29

2.  Management of the Adnexal Mass: Considerations for the Family Medicine Physician.

Authors:  Brian Bullock; Lisa Larkin; Lauren Turker; Kate Stampler
Journal:  Front Med (Lausanne)       Date:  2022-07-05

3.  Diagnostic Performance of the Ovarian-Adnexal Reporting and Data System (O-RADS) Ultrasound Risk Score in Women in the United States.

Authors:  Priyanka Jha; Akshya Gupta; Timothy M Baran; Katherine E Maturen; Krupa Patel-Lippmann; Hanna M Zafar; Aya Kamaya; Neha Antil; Lisa Barroilhet; Elizabeth A Sadowski
Journal:  JAMA Netw Open       Date:  2022-06-01

4.  Accuracy of Magnetic Resonance Imaging for Identifying Ovarian Cancer in a Community-Based Setting.

Authors:  Ruby Lin; Yun-Yi Hung; Julia Cheng; Elizabeth Suh-Burgmann
Journal:  Womens Health Rep (New Rochelle)       Date:  2022-01-31

5.  Interobserver agreement between eight observers using IOTA simple rules and O-RADS lexicon descriptors for adnexal masses.

Authors:  Neha Antil; Preethi R Raghu; Luyao Shen; Thodsawit Tiyarattanachai; Edwina M Chang; Craig W K Ferguson; Amanzo A Ho; Amelie M Lutz; Aladin J Mariano; L Nayeli Morimoto; Aya Kamaya
Journal:  Abdom Radiol (NY)       Date:  2022-06-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.